Progressive Differentiated Thyroid Cancer: Best Use of the Tyrosine Kinase Inhibitors

Volume 14, Issue 5, Supplement 9 May 2016 Moderator Marcia S. Brose, MD, PhD Director, Center for Rare Cancers and Personalized Therapy Abramson Cancer Center Associate […]

The Changing Landscape in the Frontline Treatment of Chronic Lymphocytic Leukemia

Volume 14, Issue 5, Supplement 8 May 2016 Discussants John M. Pagel, MD, PhD Chief, Hematologic Malignancies Director, Hematopoietic Stem Cell Transplantation Program Swedish Cancer Institute […]

Highlights in GEP-NETs From the 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease

Volume 14, Issue 5, Supplement 7 May 2016 Highlights in GEP-NETs From the 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease […]

Back to Archive